NFG
ABMD

Next Financial Group’s Abiomed Inc ABMD Stock Holding History

Next Financial Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$33K Sell
93
-245
-72% -$82.8K ﹤0.01% 1681
2021
Q3 		$110K Buy
338
+5
+2% +$1.69K 0.01% 1072
2021
Q2 		$104K Buy
333
+9
+3% +$2.76K 0.01% 1094
2021
Q1 		$103K Sell
324
-23
-7% -$7.36K 0.01% 1020
2020
Q4 		$113K Sell
347
-178
-34% -$49.2K 0.01% 919
2020
Q3 		$146K Buy
+525
New +$151K 0.02% 727
2020
Q2 		– Sell
-507
Closed -$74K – 2038
2020
Q1 		$74K Sell
507
-15
-3% -$2.49K 0.01% 859
2019
Q4 		$89K Buy
522
+328
+169% +$60.8K 0.01% 988
2019
Q3 		$35K Sell
194
-8
-4% -$1.73K ﹤0.01% 1259
2019
Q2 		$53K Buy
202
+22
+12% +$5.84K 0.01% 1146
2019
Q1 		$51K Sell
180
-325
-64% -$108K 0.01% 731
2018
Q4 		$164K Buy
505
+250
+98% +$86.8K 0.03% 439
2018
Q3 		$115K Buy
+255
New +$101K 0.05% 319
2017
Q2 		– Sell
-210
Closed -$27K – 2006
2017
Q1 		$27K Hold
210
– – 0.01% 946
2016
Q4 		$24K Buy
+210
New +$24.3K ﹤0.01% 1305

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Next Financial Group's ABMD Position: Q4 2021 in Review

Next Financial Group reduced its Abiomed Inc (ABMD) stake by 72% in Q4 2021, selling an estimated $82.8K and leaving 93 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #1681.

Next Financial Group first reported a position in ABMD in Q4 2016 and has held it in 15 quarters since. The position peaked at $164K in Q4 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Next Financial Group held 93 shares of Abiomed Inc worth $33K as of Q4 2021.
  • Next Financial Group sold 245 Abiomed Inc shares in Q4 2021, an estimated $82.8K.
  • Abiomed Inc made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #1681 holding.
  • Next Financial Group first reported a position in Abiomed Inc in Q4 2016 and has held it in 15 quarters since.
  • Next Financial Group's Abiomed Inc position peaked at $164K in Q4 2018.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.